University of California

Alessa Therapeutics, Inc.

Maithili Rairkar

Keith Hall

Scott Thomas

Pamela Munster

Carlos Schuler

John Maroney

Pujan Desai

Maxime D Rappaport

Tobias H Casab

Maxime Daud

Margaret McLaughlin

Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.

Drug implants containing enzalutamide and methods of use thereof

Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.

Implantable drug delivery devices for localized drug delivery

Growing community of inventors

San Francisco, CA, United States of America

Maithili Rairkar